- Home
- AMED vs CORT Comparison
AMED vs CORT Comparison
Compare AMED & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMED
- CORT
- Stock Information
- Founded
- AMED 1982
- CORT 1998
- Country
- AMED United States
- CORT United States
- Employees
- AMED N/A
- CORT N/A
- Industry
- AMED Medical/Nursing Services
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- AMED Health Care
- CORT Health Care
- Exchange
- AMED Nasdaq
- CORT Nasdaq
- Market Cap
- AMED 3.2B
- CORT 4.0B
- IPO Year
- AMED N/A
- CORT N/A
- Fundamental
- Price
- AMED $96.74
- CORT $47.17
- Analyst Decision
- AMED Hold
- CORT Strong Buy
- Analyst Count
- AMED 5
- CORT 4
- Target Price
- AMED $100.67
- CORT $66.50
- AVG Volume (30 Days)
- AMED 371.8K
- CORT 868.3K
- Earning Date
- AMED 10-29-2024
- CORT 10-30-2024
- Dividend Yield
- AMED N/A
- CORT N/A
- EPS Growth
- AMED 3875.49
- CORT 39.48
- EPS
- AMED 2.81
- CORT 1.13
- Revenue
- AMED $2,289,626,000.00
- CORT $569,610,000.00
- Revenue This Year
- AMED $7.05
- CORT $39.78
- Revenue Next Year
- AMED $5.93
- CORT $18.72
- P/E Ratio
- AMED $34.35
- CORT $41.70
- Revenue Growth
- AMED 2.70
- CORT 33.04
- 52 Week Low
- AMED $89.55
- CORT $20.84
- 52 Week High
- AMED $98.95
- CORT $48.39
- Technical
- Relative Strength Index (RSI)
- AMED 50.50
- CORT 69.84
- Support Level
- AMED $96.17
- CORT $44.64
- Resistance Level
- AMED $97.12
- CORT $47.17
- Average True Range (ATR)
- AMED 0.54
- CORT 1.84
- MACD
- AMED 0.07
- CORT -0.13
- Stochastic Oscillator
- AMED 73.61
- CORT 71.23
About AMED Amedisys Inc
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.